Document:

Monthly Payment Date Statement

 Exhibit 10.1 
  

							
	JPMorgan Chase Bank – Structured Finance Services	  	 
	 4 New York Plaza, 6th Floor
	  	Distribution Date: 10/25/04
	 New York, NY 10004-2477
	  	 
	 Officer:
	  	 Taoheed A. Agbabiaka
	  	 ph: 212-623-4481
	  	 
	 	  	 	  	 fax: 212-623-5858
	  	 

  
 GreenPoint Mortgage
Securities LLC 
  
 GreenPoint Home Equity Loan Trust 2004-1

  
 Home Equity Loan Asset-Backed Notes 
 Series 2004-1 
  

																	
	Distribution In Dollars
									
	 Class

	  	 Original
 Face
 Value

	  	 Beginning
Principal
 Balance

	  	Principal

	  	Interest

	  	Total

	  	Realized
Loses

	  	Deferred
Interest

	  	 Ending
 Principal
 Balance

	 A1
	  	202,045,000.00	  	116,578,048.39	  	8,227,663.57	  	187,690.66	  	8,415,354.23	  	0.00	  	0.00	  	108,350,384.82
	 TOTALS
	  	202,045,000.00	  	116,578,048.39	  	8,227,663.57	  	187,690.66	  	8,415,354.23	  	0.00	  	0.00	  	108,350,384.82

  

													
	Factor Information Per $1000 Of Original Face
							
	 Class

	  	Cusip

	  	Beginning
Principal

	  	Principal

	  	Interest

	  	Total

	  	Ending
Principal

	 A1
	  	395385AQ0	  	576.99051394	  	40.72193605	  	0.92895474	  	41.65089079	  	536.26857789
	 TOTALS
	  	 	  	576.99051394	  	40.72193605	  	0.92895474	  	41.65089079	  	536.26857789

  

										
	Pass-Through Rates	 
				
	 Class

	  	Previous

	 	 	Current

	 	 	Next

	 
	 A1
	  	1.845000	%	 	0.000000	%	 	0.000000	%Consulting and Subscription Agreement

 Exhibit 4.1 
  
 Consulting and Subscription Agreement 
  
 THIS CONSULTING AND SUBSCRIPTION AGREEMENT (the
“Agreement”) entered into as of November 5, 2004, by and between E Med Future, Inc., a Nevada corporation (the “Company”), and Kenneth A. Jackson (“Consultant”). 
  
 RECITALS: 
  
 A. Consultant possesses certain experience, knowledge and expertise
related to the Company, its business operations, strategy and/or regulatory requirements. 
  
 B. The Consultant has performed consulting services as an independent contractor for the Company and a subsidiary of the Company. 
  
 C. Consultant has indicated to the Company a desire and willingness to accept stock of the Company for
Consultant’s services upon the terms and conditions set forth below. 
  
 Accordingly, in consideration of the foregoing premises and the mutual covenants, promises and representations contained herein, the parties hereby agree as follows: 
  
 1. Engagement. The Company hereby engages Consultant, and Consultant
does hereby accept the engagement, to render advice and assistance as the director of research and development with respect to coordinating customer service and research and development for the Company, and as the Company and Consultant may
otherwise define, by agreement, from time to time. 
  
 2.
Duties. Consultant’s duties hereunder shall require Consultant to be available at the reasonable request of the Company to render advice and assistance, in the areas of customer service, product research and development and other matters
within Consultant’s expertise. 
  
 3. Assignment of
Rights. Consultant hereby assigns and agrees to assign to the Company or its designee all of his right, title and interest in all inventions, developments and discoveries relating to the Company’s business made or conceived by Consultant
while retained by the Company, including, without limitation, the NeedleZap dental parking station and butterfly needle burner (collectively, “Developments”). Consultants will fully disclose all Developments to the Company when made.
Consultant agrees to cooperate fully with the Company at all times in connection with the assignment, protection, maintenance and enforcement of the Developments. 
  
 4. Compensation. The Company agrees to pay to Consultant, as full compensation for Consultant’s availability,
labors, efforts, services, covenants and agreements provided herein, consulting fees in the amount of 300,000 shares of the Company’s common stock. 

 5. Independent Contractor. The parties mutually acknowledge that Consultant is not an employee of
the Company for any purpose whatsoever, but is and shall be at all times an independent contractor. The Company shall not have control over Consultant as to the location of Consultant’s place of business, the employment of personnel, or the
manner or means of the performance of his duties and responsibilities hereunder (except as specifically provided in this Agreement). As an independent contractor, all expenses for the operation of Consultant’s activities, including without
limitation, insurance, employees (including the withholding and payment of all applicable taxes with respect to employees), office rent, supplies, telephone, facsimile and taxes shall be borne by Consultant. 
  
 6. Covenants of Consultant. Consultant acknowledges that the work
which Consultant may perform may provide Consultant with access to confidential information belonging to the Company in connection with the performance by Consultant of Consultant’s duties pursuant to this Agreement, and that the Company would
not enter into this Agreement but for the covenants of Consultant contained in this paragraph. Accordingly, Consultant covenants and agrees to receive all confidential information of the Company in strict confidence and to take all reasonable steps
to guard against unauthorized disclosure or dissemination of the confidential information. 
  
 7. Acknowledgement of the Company. The Company acknowledges that the availability of the Consultant to provide services hereunder is of particular value to the Company and further acknowledges that the amounts
due Consultant hereunder are, in all events, payable to Consultant without regard to the number, volume or duration of the services actually performed or time actually expended by Consultant during the term of this Agreement. 
  
 8. Termination. Upon instruction by the Company: (i) Consultant shall
immediately thereupon cease and desist from acting on behalf of the Company in any manner whatsoever; and (ii) Consultant shall return to the Company any documents, forms, written information, or other data provided by the Company to Consultant
during the course and operation of this Agreement, including both confidential information and information which is not confidential. 
  
 9. Assignment. This Agreement is a personal services contract and it is expressly agreed that the rights and interests of Consultant and the
Company hereunder may not be sold, transferred, assigned, pledged or hypothecated. 
  
 10. Severability. In case any one or more of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any respect by a court of competent
jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement, but this Agreement shall be construed as if such invalid, illegal, or unenforceable provision had never been contained herein.

  
 11. Governing Law. This Agreement and all provisions
hereunder shall be governed by and construed in accordance with the substantive law of the State of Ohio. 
  

 2 

 12. Amendment. This Agreement may not be changed orally, but may be amended, superseded, cancelled
or modified, and the terms hereof may be waived, only by an instrument in writing signed by each of the parties, or, in the case of a waiver, signed by the party against whom enforcement of such waiver is being sought. 
  
 13. Entire Agreement. This Agreement embodies the entire agreement and
understanding between the Company and Consultant with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral or written, with respect thereof. 
  
 IN WITNESS WHEREOF, the parties have hereunto executed this Agreement on the
date first set forth above. 
  

	
	E MED FUTURE, INC.
	
	 /s/ D. Dane Donohue

	By Dane D. Donohue, Executive Vice President
	
	 /s/ Kenneth A. Jackson

	Kenneth A. Jackson

  

 3Third Amendment to Employment Agreement

 Exhibit 10.1 
  
 THIRD AMENDMENT TO EMPLOYMENT AGREEMENT 
  
 This Third Amendment to Employment Agreement (this “Amendment”) is entered into effective as of November 16, 2004,
by and among SeraCare Life Sciences, Inc., a California corporation (the “Corporation”) and Michael F. Crowley II (“Crowley”). 
  
 WHEREAS, SeraCare, Inc. (the former parent of the Corporation, now known as Biomat USA, Inc.) and Crowley entered into that certain Employment Agreement,
dated November 1, 2000 (as amended by the First Amendment and Second Amendment, the “Employment Agreement”). 
  
 WHEREAS, pursuant to that certain Assignment and Assumption Agreement, dated August 24, 2001, SeraCare, Inc. assigned its rights and obligations under the
Employment Agreement to the Corporation. 
  
 WHEREAS, pursuant to
that certain amendment to Employment Agreement, dated November 6, 2001 (the “First Amendment”), the Corporation and Crowley extended the term of the Employment Agreement to September 25, 2004. 
  
 WHEREAS, pursuant to that certain second amendment to Employment Agreement,
dated June 4, 2003 (the “Second Amendment”), the Corporation and Crowley extended the term of the Employment Agreement to September 25, 2005. 
  
 WHEREAS, the Corporation and Crowley wish to amend the Employment Agreement as provided herein. 
  
 NOW, THEREFORE, in consideration of the foregoing recitals, the parties
hereto, intending to be legally bound, agree as follows: 
  
 1.
Amendments to Employment Agreement. 
  
 a. Section 8 of the
Employment Agreement is hereby amended by extending the term of the Employment Agreement until September 25, 2006. 
  
 b. Effective as of November 1, 2004, Crowley’s annual base compensation under the Employment Agreement is increased from $175,000 to $275,000.

  
 c. Crowley’s title under the Employment Agreement is
hereby confirmed as President and Chief Executive Officer of the Corporation. 
  
 d. Except as amended by this Amendment, the provisions of the Employment Agreement shall continue for all purposes without interruption and the Employment Agreement shall remain in full force and effect. 

 2. Governing Law. The validity of this Amendment and the interpretation and performance of all of
its terms shall be controlled by the substantive law of California, including California law concerning the interpretation and performance of contracts. 
  
 3. Counterparts. This Amendment may be executed in counterparts, any one of which need not contain the signatures of more than one party, but all
such counterparts when taken together will constitute one and the same instrument. 

 IN WITNESS WHEREOF, the undersigned parties have caused this Amendment to be duly executed and delivered
as of the date set forth above. 
  

			
	CORPORATION:
	
	SERACARE LIFE SCIENCES, INC.
		
	By:	 	 /s/ Jerry L. Burdick

	Name:	 	Jerry L. Burdick
	Title:	 	Secretary

  

	
	CROWLEY:
	
	 /s/ Michael F. Crowley, Jr.

	Michael F. Crowley, Jr.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]